Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
23/10/26	₹128.43	-2.00%	9,957
22/10/26	₹131.05	-2.00%	11,514
21/10/26	₹133.72	-4.99%	106,424
19/10/26	₹140.75	+4.53%	196,125
16/10/26	₹134.65	+5.00%	104,608

End-of-day quote NSE India S.E.

More quotes

End-of-day quote NSE India S.E. 23/10/2026			5-day change	1st Jan Change
128.43 ^INR	-2.00%		-4.62%	+83.47%

10-06	8,694,345 Equity Shares of Valiant Laboratories Limited are subject to a Lock-Up Agreement Ending on 6-OCT-2026.	CI
09-30	Valiant Laboratories Limited Announces Change in Registered Office Address	CI

Market Cap	6.98B 73.48M 65.62M 60.62M 54.93M 103M 104M 729M 289M 3.65B 276M 270M 11.52B	P/E 2025	-150x	P/E 2026	-79.4x
Enterprise Value	7.11B 74.86M 66.85M 61.75M 55.96M 105M 106M 743M 294M 3.72B 281M 275M 11.74B	EV / Sales 2025	2.83x	EV / Sales 2026	1.24x
Free-Float	23.22%	Yield 2025 *	-	Yield 2026	-

Markets		Quality
NSE India S.E.	VALIANTLAB	End-of-day quote
Bombay S.E.	VALIANTLAB	Delayed

10-06	8,694,345 Equity Shares of Valiant Laboratories Limited are subject to a Lock-Up Agreement Ending on 6-OCT-2026.	CI
09-30	Valiant Laboratories Limited Announces Change in Registered Office Address	CI
08-11	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-10	Valiant Laboratories Limited Approves the Opening of New Corporate Office	CI
05-20	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
05-14	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-23	Valiant Laboratories Limited Announces Resignation of Bhanudas D. Patil as Q.C Manager, Senior Management Personnel, Effective April 22, 2026	CI
02-11	Valiant Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-15	Valiant Laboratories Ltd receives notice for total tax demand of approx. 125.3 million rupees	RE
11-12	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-07	Valiant Laboratories Arm Begins Commercial Operations at New Unit in Gujarat, India; Shares Up 4%	MT
25/09/25	Valiant Laboratories Limited Approves Change in Designation of Paresh Shah from Executive Director to Whole-Time Director, Effective September 25, 2025	CI
09/08/25	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI

Valiant Laboratories Limited Stock

Stocks

VALIANTLAB

INE0JWS01017

Specialty Chemicals

Valuation: Valiant Laboratories Limited

Chart: Valiant Laboratories Limited

Latest news: Valiant Laboratories Limited

Quotes and Performance

Price Extremes

Managers and Directors: Valiant Laboratories Limited

Other Specialty Chemicals

Financials

Company Profile

Quotes

1 day	-2.00%
1 week	-4.62%
Current month	+1.74%
1 month	+4.29%
3 months	+108.83%
6 months	+69.68%
Current year	+83.47%

1 week	128.43	141.38
1 month	113	141.38
Current year	49.51	141.38
1 year	49.51	141.38
3 years	49.51	214.95
5 years	49.51	214.95
10 years	49.51	214.95

Manager	Title	Age	Since
Santosh Vora CEO	Chief Executive Officer	32	21/08/2021
Paresh Shah DFI	Director of Finance/CFO	66	16/08/2021
Akshay Dnyaneshwar Gangurde CMP	Compliance Officer	-	09/07/2025

Director	Title	Age	Since
Santosh Vora BRD	Director/Board Member	32	21/08/2021
Sonal Amit Vira BRD	Director/Board Member	44	16/02/2022
Paresh Shah BRD	Director/Board Member	66	16/08/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALIANT LABORATORIES LIMITED	-2.00%	-4.62%	+47.86%	-26.63%	73.48M
ECOLAB INC.	-1.29%	-0.12%	+4.08%	+80.05%	80.88B
GIVAUDAN SA	+0.45%	+1.99%	+12.89%	+41.40%	44.68B
SIKA AG	-2.33%	-1.29%	+2.39%	-16.46%	35.05B
HENKEL AG & CO. KGAA	-0.13%	-0.40%	+9.82%	+17.29%	33.8B
NOVONESIS A/S	+0.52%	+5.87%	+17.87%	+71.78%	33.61B
FUJIFILM HOLDINGS CORPORATION	-0.38%	-1.22%	-4.29%	+21.94%	25.85B
EMS-CHEMIE HOLDING AG	-0.85%	-0.96%	+52.75%	+44.55%	24.84B
DUPONT DE NEMOURS, INC.	+1.07%	+4.68%	-43.81%	-37.48%	18.44B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	+1.37%	-5.08%	+25.44%	+10.46%	16.32B
Average	-0.36%	-0.28%	+12.50%	+20.69%	31.35B
Weighted average by Cap.	-0.45%	+0.44%	+8.71%	+37.94%

	2025	2026
Net sales	1.33B 14.05M 12.55M 11.59M 10.5M 19.65M 19.98M 139M 55.22M 699M 52.73M 51.61M 2.2B	2.37B 25.02M 22.34M 20.64M 18.7M 34.99M 35.57M 248M 98.32M 1.24B 93.88M 91.88M 3.92B
Net income	-22.01M -232K -207K -191K -173K -324K -330K -2.3M -911K -11.53M -870K -852K -36.36M	-32.68M -344K -307K -284K -257K -481K -489K -3.42M -1.35M -17.12M -1.29M -1.26M -53.98M
Net Debt	453M 4.77M 4.26M 3.94M 3.57M 6.67M 6.78M 47.36M 18.75M 237M 17.91M 17.52M 748M	131M 1.38M 1.23M 1.14M 1.03M 1.92M 1.96M 13.66M 5.41M 68.44M 5.16M 5.05M 216M